These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26562468)

  • 21. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.
    Qu Q; Ma X; Zhao Y
    ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines.
    Goel S; Mishra P
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionalized mesoporous silica nanoparticles in anticancer therapeutics.
    Barkat A; Beg S; Panda SK; S Alharbi K; Rahman M; Ahmed FJ
    Semin Cancer Biol; 2021 Feb; 69():365-375. PubMed ID: 31442571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
    Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
    Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gold nanorods coated with mesoporous silica shell as drug delivery system for remote near infrared light-activated release and potential phototherapy.
    Liu J; Detrembleur C; De Pauw-Gillet MC; Mornet S; Jérôme C; Duguet E
    Small; 2015 May; 11(19):2323-32. PubMed ID: 25580816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-Cell-Specific Nuclear-Targeted Drug Delivery by Dual-Ligand-Modified Mesoporous Silica Nanoparticles.
    Xiong L; Du X; Kleitz F; Qiao SZ
    Small; 2015 Nov; 11(44):5919-26. PubMed ID: 26426251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents.
    Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R
    Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
    Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functionalization of mesoporous silica nanoparticles with a cell-penetrating peptide to target mammalian sperm in vitro.
    Barkalina N; Jones C; Townley H; Coward K
    Nanomedicine (Lond); 2015 May; 10(10):1539-53. PubMed ID: 26008192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding caps as an autonomous drug-delivery system.
    Théron C; Gallud A; Carcel C; Gary-Bobo M; Maynadier M; Garcia M; Lu J; Tamanoi F; Zink JI; Wong Chi Man M
    Chemistry; 2014 Jul; 20(30):9372-80. PubMed ID: 24986399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating layer-by-layer chitosan-dextran sulfate-coated mesoporous silica as a pH-sensitive drug delivery system.
    Hooshyar MR; Raygan S; Mehdinavaz Aghdam R
    J Mater Sci Mater Med; 2024 Jun; 35(1):29. PubMed ID: 38884680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.